Abstracts tagged "monitoring"

Abstract Number: 0172 • ACR Convergence 2021
Assessing Relevant Joints for Monitoring CPPD Diseases: A Systematic Literature Review of Imaging Techniques by the OMERACT Ultrasound – CPPD Subgroup
Antonella Adinolfi¹, Silvia Sirotti², Garifallia Sakellariou³, Edoardo Cipolletta⁴, Emilio Filippucci⁵, Francesco Porta⁶, Piercarlo Sarzi-Puttini⁷, Carlo Alberto Scire⁸, Helen Keen⁹, Peter Mandl¹⁰, Carlos Pineda¹¹, Lene Terslev¹², Maria Antonietta D'Agostino¹³, Nemanja Damjanov¹⁴, Annamaria Iagnocco¹⁵ and Georgios Filippou¹⁶, ¹Rheumatology Unit, Grande Ospedale Metropolitano Niguarda, Milan, Italy, ²Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy, ³Division of Rheumatology, IRCCS Policlinico San Matteo Foundation, University of Pavia, Pavia, Italy, ⁴Rheumatology Unit, Department of Clinical and Molecular Sciences, Università Politecnica delle Marche, Ancona, Italy, ⁵Rheumatology Unit, Department of Clinical and Molecular Sciences, Università Politecnica delle Marche, Jesi, Italy, ⁶INS, Institute of Neurosciences, Florence, Italy, ⁷L.Sacco University Hospital, Milano, Italy, ⁸SIR Epidemiology, Research Unit, Pavia, Italy, ⁹University of Western Australia, Daglish, Australia, ¹⁰Medical University of Vienna, Vienna, Austria, ¹¹Instituto Nacional de Rehabilitacion, Mexico City, Federal District, Mexico, ¹²Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen University, Glostrup, Denmark, ¹³Rheumatology, Fondazione Policlinico Universitario “Gemelli”, IRCCS, Rome, Italy, ¹⁴University of Belgrade School of Medicine, Institute of Rheumatology, Belgrade, Serbia, ¹⁵University of Turin, Roma, Italy, ¹⁶Rheumatology Department, Luigi Sacco University Hospital, Siena, Italy
Background/Purpose: Imaging has been extensively used for the diagnosis of Calcium Pyrophosphate Deposition Disease (CPPD) but the exact prevalence of joint calcifications at imaging in…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].